COMPANION DIAGNOSTICS FORUM 2019 Precision Medicine without Borders
October 29-30, 2019 New Jersey Hospital Association Princeton, NJ
Precision Medicine has surpassed its original vision directed to genomics and cancer and now encompasses a host of diagnostic and therapeutic modalities. In the time since the formal announcement in 2015, drugs and assays have been developed based on a broader array of pathways and targets. Precision Medicine has also expanded beyond the geographic borders of the original targeted market regions to new countries, each with its own market needs and regulations.
What has driven this expansion? What challenges are presented? At this Forum, we explore how Precision Medicine has been taken up across geographic borders, expanded to include new therapeutic areas, and broadened to develop novel drugs and assay types. Of particular interest for the Forum are the challenges of bringing precision medicine to international markets – for example, how lessons learned within country can be applied (or not!) to other countries.
Talk Recordings from the previous Companion Diagnostics Forums are available to view, you will just need to fill in a simple form to view.
Compelling reasons to attend this year’s Forum:
Wider range of attendees and speakers
New exhibitors offering the latest technologies
New topics on the promotion and uptake of Precision Dx and Rx
Special panel of clinical and regulatory experts convened to discuss precision medicine and take questions in “Ask me Anything! (on Precision Medicine)”
Targeted audience: Those developing and launching precision diagnostics and therapeutics in global and domestic markets
VPs, Executive/Senior Directors, Senior Scientists in related fields
Laboratory and Technology Directors
Project Managers to manage international collaborations (technical, logistical, and transitioning projects to partners)
Technology leaders and researchers – precision tools, processes, platforms, informatics
Researchers in precision assays, diagnostics (basic, development, validation, execution)
Researchers in novel precision therapeutics – vaccines, biologics, and small molecules
VPs, Executive/Senior Directors, Directors, and Associates in licensing and regulatory
“Overall, the conference was fantastic. The quality of talks was outstanding: Michelle, Nick, Steve, Jeff, Bill, Ken, Chris Major, etc, etc Their talks were great. I really like that vendors like Nanostring and ThermoFisher gave great talks explaining the development of their approved CDx and outcome of FDA review, plus tough situations they encountered during this process. Fantastic meeting!”